FP
PAHC icon

Foundry Partners’s Phibro Animal Health PAHC Stock Holding History

Foundry Partners’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-59,206
Closed -$1.9M – 392
2018
Q4 		$1.9M Sell
59,206
-99
-0.2% -$3.73K 0.09% 270
2018
Q3 		$2.54M Sell
59,305
-93
-0.2% -$4.39K 0.1% 261
2018
Q2 		$2.73M Sell
59,398
-3,862
-6% -$171K 0.11% 248
2018
Q1 		$2.51M Sell
63,260
-148
-0.2% -$5.48K 0.11% 257
2017
Q4 		$2.12M Sell
63,408
-50,190
-44% -$1.78M 0.09% 260
2017
Q3 		$4.21M Sell
113,598
-332
-0.3% -$12.5K 0.17% 212
2017
Q2 		$4.22M Sell
113,930
-2,579
-2% -$84.2K 0.17% 205
2017
Q1 		$3.27M Buy
116,509
+37,248
+47% +$1.05M 0.14% 255
2016
Q4 		$2.32M Buy
+79,261
New +$2.16M 0.1% 295

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Foundry Partners's PAHC Position: Q1 2019 in Review

Foundry Partners sold out of Phibro Animal Health (PAHC) in Q1 2019, closing a stake of 59,206 shares — an estimated $1.9M sold.

Foundry Partners first reported a position in PAHC in Q4 2016 and held it in 9 quarters. The position peaked at $4.22M in Q2 2017. 176 funds tracked by Wall St. Rank hold PAHC as of Q1 2019.

  • Foundry Partners reported no remaining Phibro Animal Health position as of Q1 2019 after selling out during the quarter.
  • Foundry Partners sold 59,206 Phibro Animal Health shares in Q1 2019, an estimated $1.9M.
  • Foundry Partners first reported a position in Phibro Animal Health in Q4 2016 and held it in 9 quarters.
  • Foundry Partners's Phibro Animal Health position peaked at $4.22M in Q2 2017.
  • 176 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2019.

Based on Foundry Partners's 13F filing for Q1 2019, filed 22 Apr 2019.